Wound healing following myocardial infarction in the rat: Role for bradykinin and prostaglandins

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 6, 1996, Pages 1279-1285

  Frimm, Clovis de Carvalho ^a   Sun, Yao ^a   Weber, Karl T ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Bradykinin; Fibrosis; Myocardial infarction; Prostaglandins

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; COLLAGEN; COLLAGEN FIBRIL; ICATIBANT; INDOMETACIN; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DENSITOMETRY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE FIBROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WOUND HEALING;

EID: 0342903238     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0118     Document Type: Article

References (40)

1. AALTO M, KULONEN E, 1972. Effects of serotonin, indomethacin and other antirheumatic drugs on the synthesis of collagen and other proteins in granulation tissue slices. Biochem Pharmacol 21: 2835-2840.
2. BAUMGARTEN CR, LINZ W, KUNKEL G, SCHÖLKENS BA, WIEMER G, 1993. Ramaprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol 108: 293-295.
3. BROWN EJ, KLONER RA, SCHOEN FJ et al., 1983. Scar thinning due to ibuprofen administration after experimental myocardial infarction. Am J Cardiol 51: 877-883.
4. CLEUTJENS JPM, KANDALA JC, GUARDA E, GUNTAKA RV, WEBER KT, 1995. Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27: 1281-1292.
5. DAMAS J, REMACLE-VOLON G, 1992. Influence of a long-acting bradykinin antagonist, Hoe140, on some acute inflammatory reactions in the rat. Eur J Pharmacol 211: 81-86.
6. EVERS AS, MURPHREE S, SAFFITZ JE, JAKSCHIK BA, NEEDLEMAN P, 1985. Effects of endogenously produced leukotrienes, thromboxane, and prostaglandins on coronary vascular resistance in rabbit myocardial infarction. J Clin Invest 75: 992-999.
7. FANG C, ALEXANDER JW, MACMILLAN BG, AUSTIN LS, 1983. Failure of topical prostaglandin inhibitors to improve wound healing following deep partial-thickness burns. J Trauma 23: 300-304.
8. 9-bradykinin. J Biol Chem 259: 9263-9268.
9. HAMMERMAN H, KLONER RA, SCHOEN FJ, et al., 1983. Indomethacin-induced scar thinning after experimental myocardial infarction. Circulation 67: 1290-1295.
10. HAMMERMAN H, SCHOEN FJ, BRAUNWALD E, KLONER RA, 1984. Drug-induced expansion of infarct: morphologic and functional correlations. Lab Invest 69: 611-617.
11. HASHIMOTO K, HIROSE M, FURUKAWA K, HAYAKAWA H, KIMURA E, 1977. Changes in hemodynamics and bradykinin concentration in coronary sinus blood in experimental coronary artery occlusion. Jpn Heart J 18: 679-689.
12. HIGGS GA, EAKINS KE, MUGRIDGE KG, MONCASA S, VANE JR, 1980. The effects of non-steroid anti-inflammatory drugs on leukocyte migration in carrageen in-induced inflammation. Eur J Pharmacol 66: 81-86.
13. JIBORN H, AHONEN J, ZEDERFELDT B, 1980. Healing of experimental colonic anastomoses. III. Collagen metabolism in the colon after left colon resection. Am J Surg 139: 398-405.
14. JUDD JT, WEXLER BC, 1969. Myocardial connective tissue metabolism in response to injury. Histological and chemical studies of mucopolysaccharide and collagen in rat hearts after isoproterenol-induced infarction. Circ Res 25: 201-214.
15. JUGDUTT BI, AMY RWM, 1986. Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J Am Coll Cardiol 7: 91-102.
16. JUGDUTT BI, BASUALDO CA, 1989. Myocardial infarct expansion during indomethacin or ibuprofen therapy for symptomatic post infarction pericarditis. Influence of other pharmacologic agents during early remodelling. Can J Cardiol 5: 211-221.
17. JUNQUEIRA LCU, BIGNOLAS G, BRENTANI RR, 1979. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 441-455.
18. KIMURA E, HASHIMOTO K, FURUKAWA S, HAYAKAWA H, 1973. Changes in bradykinin level in coronary sinus blood after the experimental occlusion of a coronary artery. Am Heart J 85: 635-647.
19. LAMONTAGNE D, KONIG A, BASSENGE E, BUSSE R, 1992. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 20: 652-657.
20. LANYON LE, 1992. Control of bone architecture by functional load bearing. J Bone Min Res 7: S369-S375.
21. 2-bradykinin receptor antagonist HOE140 abolishes the anti-hypertrophic effect of ramipril. Br J Pharmacol 105: 771-772.
22. 2-receptors alters the adult cardiovascular phenotype in rats. Hypertension 25: 453-459.
23. MASTBOOM WJB, HENDRIKS T, VAN ELTEREN P, DE BOER HHM, 1991. The influence of NSAIDs on experimental intestinal anastomoses. Dis Colon Rectum 34: 236-243.
24. MONCADA S, 1992. The 1991 Ulf von Euler lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand 145: 201-227.
25. NEEDLEMAN P, MARSHALL GR, SOBEL BE, 1975. Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ Res 37: 802-808.
26. NEUPERT G, MÜLLER P, 1975. Growth inhibition and morphological changes caused by indomethacin in fibroblasts in vitro. Exp Pathol (Jena) 11: 1-9.
27. NODA K, SASAGURI M, IDEISHI M, IKEDA M, ARAKAWA K, 1993. Role of locally formed angiotensin II and bradykinin in the reduction of myocardial infarct size in dogs. Cardiovasc Res 27: 334-340.
28. PICK R, JALIL JE, JANICKI JS, WEBER KT, 1989. The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol 134: 365-371.
29. ROZENGURT E, STROBANT P, WATERFIELD MD, DEUEL TF, KEEHAN M, 1983. Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production. Cell 34: 265-272.
30. SMITS JFM, VAN KRIMPEN C, SCHOEMAKER RG, CLEUTJENS JPM, DAEMEN MJAP, 1992. Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemo-dynamics, myocardial DNA synthesis, and interstitial collagen content. J Cardiovasc Pharmacol 20: 772-778.
31. SRINIVAS GR, CHICHESTER CO, BARRACH HJ, MATONEY AL, 1994. Effects of certain antiarthritic agents on the synthesis of type II collagen and glycosaminoglycans in rat chondrosarcoma cultures. Agents Actions 41: 193-199.
32. SUN Y, WEBER KT, 1994. Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc Res 28: 1623-1628.
33. SUN Y, CLEUTJENS JPM, DIAZ-ARIAS AA, WEBER KT, 1994. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc Res 28: 1423-1432.
34. SUN Y, RATAJSKA A, WEBER KT, 1995. Bradykinin receptor and tissue ACEbinding in myocardial fibrosis: response to chronic angiotensin II or aldosterone administration in rats. J Mol Cell Cardiol 27: 813-822.
35. THRALL RS, MCCORMICK JR, JACK RM, MCREYNOLDS RA, WARD PA, 1979. Bleomycin-induced pulmonary fibrosis in the rat. Inhibition by indomethacin. Am J Pathol 95: 117-130.
36. VAN KRIMPEN C, SCHOEMAKER RG, CLEUTJENS JPM, et al., 1991. Angiotensin I converting enzyme inhibitors and cadiac remodeling. Basic Res Cardiol 86 [Suppl. 1]: 149-155.
37. WAHL SM, 1981. The role of mononuclear cells in the wound repair process. In: (Eds P. Dineen, G. Hildick-Smith). The Surgical Wound. Lea & Febiger, Philadelphia: 63-66.
38. WEBER DR, STROUD ED, PRESCOTT SM, 1989. Arachidonate metabolism in cultured fibroblasts derived from normal and infarcted canine heart. Circ Res 65: 671-683.
39. WEBER KT, 1995. Snakes and seaweed: a case of the swollen organ. Cardiovasc Res 29: 457-462.
40. WEBER KT, SUN Y, KATWA LC, CLEUTJENS JPM, 1995. Connective tissue: a metabolic entity? J Mol Cell Cardiol 27: 107-120.